ROCKVILLE, Md. (AP) _ MacroGenics Inc. (MGNX) on Thursday reported a loss of $46.9 million in its second quarter.
On a per-share basis, the Rockville, Maryland-based company said it had a loss of 94 cents.
The results missed Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 88 cents per share.
The biopharmaceutical company posted revenue of $20.3 million in the period, topping Street forecasts. Three analysts surveyed by Zacks expected $14.2 million.
MacroGenics shares have more than doubled since the beginning of the year. In the final minutes of trading on Thursday, shares hit $26.75, an increase of 82% in the last 12 months.